HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
Current candidate vaccines fail to protect primates against challenge with human immunodeficiency virus (HIV) in the presence of antibody responses; this underlines the importance of studying cell-mediated immunity to HIV and identifying specific epitopes that stimulate cytotoxic T lymphocytes (CTL)...
Asıl Yazarlar: | Nixon, D, Townsend, A, Elvin, J, Rizza, C, Gallwey, J, Mcmichael, A |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
1988
|
Benzer Materyaller
-
HIV-gag-specific cytotoxic T lymphocytes.
Yazar:: Nixon, D, ve diğerleri
Baskı/Yayın Bilgisi: (1989) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
Yazar:: Townsend, A, ve diğerleri
Baskı/Yayın Bilgisi: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
Yazar:: Townsend, A, ve diğerleri
Baskı/Yayın Bilgisi: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
Yazar:: Townsend, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006) -
Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
Yazar:: Dorrell, L, ve diğerleri
Baskı/Yayın Bilgisi: (2000)